{"id":242442,"date":"2026-08-09T12:15:46","date_gmt":"2026-08-09T17:15:46","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/08\/comparative-cardiovascular-outcomes-of-tirzepatide-and-glucagon%e2%80%90like-peptide%e2%80%901-receptor-agonists-in-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease"},"modified":"2026-08-09T12:15:46","modified_gmt":"2026-08-09T17:15:46","slug":"comparative-cardiovascular-outcomes-of-tirzepatide-and-glucagon%e2%80%90like-peptide%e2%80%901-receptor-agonists-in-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/08\/comparative-cardiovascular-outcomes-of-tirzepatide-and-glucagon%e2%80%90like-peptide%e2%80%901-receptor-agonists-in-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease","title":{"rendered":"Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon\u2010Like Peptide\u20101 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/comparative-cardiovascular-outcomes-of-tirzepatide-and-glucagone28090like-peptidee280901-receptor-agonists-in-patients-with-type-2-diabetes-and-atherosclerotic-cardiovascular-disease2.jpg\"><\/a><\/p>\n<p>BackgroundTo evaluate the association between tirzepatide use and 1\u2010year risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease, compared with GLP\u20101 (glucagon\u2010like peptide\u20101) receptor agonists.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BackgroundTo evaluate the association between tirzepatide use and 1\u2010year risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease, compared with GLP\u20101 (glucagon\u2010like peptide\u20101) receptor agonists.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-242442","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=242442"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/242442\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=242442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=242442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=242442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}